EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.
Choi YL; Soda M; Yamashita Y; Ueno T; Takashima J; Nakajima T; Yatabe Y; Takeuchi K; Hamada T; Haruta H; Ishikawa Y; Kimura H; Mitsudomi T; Tanio Y; Mano H; The New England Journal Of Medicine, 2010, vol. 363, issue 18, p 1734, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation